Michael Bonney - Tekla Life Insider

Tekla Life Sciences Investors -- USA Fund  

USD 21.54  0.23  1.08%

Independent Trustee

Mr. Michael W. Bonney is an Independent Trustee of HQ Life Sciences Investors., since 2011. Mr. Bonney is the Chief Executive Officer and member of the Board of Directors of Cubist Pharmaceuticals, Inc. until December, 2014, providing each Fund with valuable insight into operating matters relating to biotech companies and the overall healthcare industry. He serves on the Valuation Committee and is Chairman of the Governance and Nominating Committee of each Fund
Age: 57  Executive Since 2011      
Bonney is also a Director of Alnylam Pharmaceuticals, Inc. and is Chairman of the Board of Trustees of Bates College. He holds a BA degree from Bates College.

Management Performance (%)

Fund Summary

The fund is listed under null category and is part of null family.

Did you try this?

Run Piotroski F Score Now
   

Piotroski F Score

Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Hide  View All  Next  Launch Piotroski F Score
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Tekla Life Sciences Investors to your portfolio

Top Management

Tekla Life Sciences Leadership Team
William Reardon, Executive, CPA
Michael Bonney, Executive
Oleg Pohotsky, Executive, MBA
Lucinda Stebbins, Executive, CPA
Daniel Omstead, President
Uwe Reinhardt, Executive, Ph.D
Rakesh Jain, Executive

Fund Performance

Tekla Life Performance Indicators